Ebronucimab (Anti-PCSK9)

Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.

• Supplier: Selleck Chemicals
• Product #: A2843
• Sku #: A2843-1mg